英文别名 |
Alobresib;3QBL0BLP3D;Alobresib [INN];BDBM249306;DB14970;(2-Cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1hbenzimidazol-4-yl)(dipyridin-2-yl)methanol;GS-5829;C92675;UNII-3QBL0BLP3D;Gs 5829;Alobresib (GS-5829)?;F81315;(2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-1,3-benzodiazol-4-yl)bis(pyridin-2-yl)methanol;CHEMBL3982690;GS5829;ALOBRESIB [WHO-DD];EX-A3724;GS5829,alobresib;CS-0031496;DA-70720;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-1,3-benzodiazol-4-yl]bis(pyridin-2-yl)methanol;MS-27842;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-benzimidazol-4-yl]-dipyridin-2-ylmethanol;BCP33313;AKOS040759425;SCHEMBL16225351;1637771-14-2;US9458145, 1020-104;Alobresib (GS-5829);(2-CYCLOPROPYL-6-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-4-YL)DI(PYRIDIN-2-YL)METHANOL;[2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-;s8961;GS-5829;GS 5829;GS5829;1H-benzimidazol-4-yl]di(pyridin-2-yl)methanol;alobresibum;2-cyclopropyl-5-(3,5-dimethyl-4-isoxazolyl)-alpha,alpha-di-2-pyridinyl-1H-benzimidazole-7-methanol;HY-109050 |